Mesalamine DR 400 MG capsule 180S
Ended Awarded
- Contract number
- SPE2DB25FX30J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,952
Award facts
- Contract value 100% obligated
- $1,952.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Mesalamine DR 400 mg capsules (180-count units) with a ceiling value of $1,952.10. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply medications and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal healthcare vendor through its extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This transaction exemplifies the company's role as a primary pharmaceutical supplier for federal military and veteran healthcare procurement needs.
Quick answers
Who was awarded contract SPE2DB25FX30J?
SPE2DB25FX30J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FX30J worth?
The government has obligated $1,952 on SPE2DB25FX30J.
Is contract SPE2DB25FX30J an order under another contract?
Yes. SPE2DB25FX30J is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX30J competed?
The extent of competition for SPE2DB25FX30J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award